If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
22nd Jun 20117:00 amRNSTransaction in Own Shares
21st Jun 20113:55 pmRNSTransfer of Treasury Shares
2nd Jun 20112:52 pmRNSScrip Dividend Alternative
1st Jun 201110:42 amRNSTotal Voting Rights
1st Jun 201110:39 amRNSBlocklisting Interim Review
12th May 20114:11 pmRNSResult of AGM
12th May 20117:00 amRNSInterim Management Statement
12th May 20117:00 amRNSTransaction in Own Shares
4th May 20114:48 pmRNSTotal Voting Rights
4th May 20114:46 pmRNSAnnual Information Update
4th May 20113:39 pmRNSCompany Secretary Change
28th Apr 20117:00 amRNSTransaction in Own Shares
27th Apr 201111:40 amRNSDirector/PDMR Shareholding
27th Apr 20117:00 amRNSTransaction in Own Shares
26th Apr 20117:00 amRNSTransaction in Own Shares
21st Apr 20117:00 amRNSTransaction in Own Shares
13th Apr 20115:41 pmRNSNotification of Major Interests in Shares
11th Apr 20117:00 amRNSTransaction in Own Shares
8th Apr 20113:57 pmRNSDirector/PDMR Shareholding
7th Apr 20113:37 pmRNSDirector/PDMR Shareholding
7th Apr 20119:29 amRNSNotice of AGM
7th Apr 20117:00 amRNSTransaction in Own Shares
6th Apr 20119:35 amRNSDirector/PDMR Shareholding
6th Apr 20117:00 amRNSTransaction in Own Shares
5th Apr 201110:26 amRNSDirector/PDMR Shareholding
5th Apr 20117:00 amRNSTransaction in Own Shares
4th Apr 20113:27 pmRNSDirector/PDMR Shareholding
4th Apr 20117:00 amRNSTransaction in Own Shares
1st Apr 20115:14 pmRNSDirector/PDMR Shareholding
1st Apr 20119:39 amRNSDirector/PDMR Shareholding
1st Apr 20119:37 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSTransaction in Own Shares
28th Mar 20112:55 pmRNSDirector/PDMR Shareholding
28th Mar 201110:14 amRNSDirector/PDMR Shareholding
28th Mar 20117:00 amRNSTransaction in Own Shares
23rd Mar 201112:05 pmRNSShare Buy-Back Programme
23rd Mar 20117:02 amRNSDirectorate Change
23rd Mar 20117:01 amRNSHuntsworth plc acquires Atomic PR
23rd Mar 20117:00 amRNSPreliminary Results
14th Mar 20117:00 amRNSTransaction in Own Shares
9th Mar 20117:00 amRNSTransaction in Own Shares
7th Mar 20117:00 amRNSTransaction in Own Shares
1st Mar 20112:04 pmRNSTotal Voting Rights
28th Feb 20117:00 amRNSTransaction in Own Shares
16th Feb 20112:36 pmRNSNotice of Results
2nd Feb 20119:51 amRNSBlocklisting Interim Review
2nd Feb 20119:49 amRNSBlocklisting Interim Review
18th Jan 20119:26 amRNSBlocklisting Interim Review
18th Jan 20119:24 amRNSBlocklisting Interim Review
4th Jan 201110:23 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.